Results 251 to 260 of about 957,553 (357)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine. [PDF]

open access: yesIran J Basic Med Sci
Salmani-Javan E   +2 more
europepmc   +1 more source

POS0032 Effectiveness of Switching from IL-6 Inhibitors to Other Targeted Molecular Therapies

open access: hybrid
Tadashi Okano   +11 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Targeted Sequencing in Gastric Cancer: Association with Tumor Molecular Characteristics and FLOT Therapy Effectiveness [PDF]

open access: gold
Л. В. Спирина   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy